Emerging roles for the pH-sensing G protein-coupled receptors in response to acidotic stress by Sanderlin, Edward J et al.
© 2015 Sanderlin et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0)  
License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further 
permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on 
how to request permission may be found at: http://www.dovepress.com/permissions.php
Cell Health and Cytoskeleton 2015:7 99–109
Cell Health and Cytoskeleton Dovepress
submit your manuscript | www.dovepress.com
Dovepress 
99
R e v i e w
open access to scientific and medical research
Open Access Full Text Article
http://dx.doi.org/10.2147/CHC.S60508
emerging roles for the pH-sensing G protein-





1Department of internal Medicine, 
Brody School of Medicine, east 
Carolina University, Greenville, 
NC, USA; 2Department of Anatomy 
and Cell Biology, Brody School of 
Medicine, east Carolina University, 
Greenville, NC, USA
Correspondence: Li v Yang 
Division of Hematology/Oncology, 
Department of internal Medicine, 
Brody School of Medicine,  
east Carolina University,  
600 Moye Boulevard, Brody 3e-127,  
Greenville, NC 27834, USA 
Tel +1 252 744 3419 
Fax +1 252 744 3418 
email yangl@ecu.edu
Abstract: Protons (hydrogen ions) are the simplest form of ions universally produced by cellular 
metabolism including aerobic respiration and glycolysis. Export of protons out of cells by a 
number of acid transporters is essential to maintain a stable intracellular pH that is critical for 
normal cell function. Acid products in the tissue interstitium are removed by blood perfusion and 
excreted from the body through the respiratory and renal systems. However, the pH homeostasis 
in tissues is frequently disrupted in many pathophysiologic conditions such as in ischemic tissues 
and tumors where protons are overproduced and blood perfusion is compromised. Consequently, 
accumulation of protons causes acidosis in the affected tissue. Although acidosis has profound 
effects on cell function and disease progression, little is known about the molecular mecha-
nisms by which cells sense and respond to acidotic stress. Recently a family of pH-sensing G 
protein-coupled receptors (GPCRs), including GPR4, GPR65 (TDAG8), and GPR68 (OGR1), 
has been identified and characterized. These GPCRs can be activated by extracellular acidic pH 
through the protonation of histidine residues of the receptors. Upon activation by acidosis the 







 pathways to regulate cell behavior. Studies have revealed the biological roles of the 
pH-sensing GPCRs in the immune, cardiovascular, respiratory, renal, skeletal, endocrine, and 
nervous systems, as well as the involvement of these receptors in a variety of pathological condi-
tions such as cancer, inflammation, pain, and cardiovascular disease. As GPCRs are important 
drug targets, small molecule modulators of the pH-sensing GPCRs are being developed and 
evaluated for potential therapeutic applications in disease treatment.
Keywords: acidosis, GPCR, GPR4, GPR65 (TDAG8), GPR68 (OGR1)
Introduction
Cellular metabolism produces acid as a byproduct. Metabolism of each glucose mol-
ecule by glycolysis generates two pyruvate molecules. Under anaerobic conditions 
the metabolism of pyruvate results in the production of the glycolytic end product 
lactic acid, which has a pKa of 3.9. Lactic acid is deprotonated at the carboxyl group 
and results in one lactate ion and one proton at the physiological pH. Under aerobic 
conditions pyruvate is converted into acetyl-CoA and CO
2
 in the mitochondria. CO
2
 
in water forms a chemical equilibrium of carbonic acid and bicarbonate, an important 
physiological pH buffering system. The body must maintain suitable pH for proper 
physiological functions. Some regulatory mechanisms to control systemic pH are 
respiration, renal excretion, bone buffering, and metabolism.1–4 The respiratory system 
can buffer the blood by excreting carbonic acid as CO
2
 while the kidney responds 
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physiological pH. Bone buffering helps maintain systemic pH 
by Ca2+ reabsorption and mineral dissolution. Collectively, 
it is clear that several biological systems require tight regu-
lation to maintain pH for normal physiological functions. 
Cells utilize vast varieties of acid-base transporters for 
proper pH homeostasis within each biological context.5–8 
Some such transporters are H+-ATPase, Na+/H+ exchanger, 
Na+-dependent HCO
3
-/Cl- exchanger, Na+-independent anion 
exchanger, and monocarboxylate transporters. Cells can also 
maintain short-term pH homeostasis of the intracellular pH 
by rapid H+ consuming mechanisms. Some such mechanisms 
utilize metabolic conversions that move acids from the 
cytosol into organelles. Despite these cellular mechanisms 
that tightly maintain proper pH homeostasis, there are 
many diseases whereby pH homeostasis is disrupted. These 
pathological conditions are characterized by either local or 
systemic acidosis. Systemic acidosis can occur from respi-
ratory, renal, and metabolic diseases and septic shock.1–4,9 
Additionally, local acidosis is characterized in ischemic 
tissues, tumors, and chronically inflamed conditions such 
as in asthma and arthritis caused by deregulated metabolism 
and hypoxia.10–15
Acidosis is a stress for the cell. The ability of the cell 
to sense and modulate activity for adaptation to the stress-
ful environment is critical. There are several mechanisms 
whereby cells sense acidosis and modulate cellular functions 
to facilitate adaptation. Cells can detect extracellular pH 
changes by acid sensing ion channels (ASICs) and transient 
receptor potential (TRP) channels.16 Apart from ASIC and 
TRP channels, extracellular acidic pH was shown to stimulate 
inositol polyphosphate formation and calcium efflux.17,18 
This suggested the presence of an unknown cell surface 
receptor that may be activated by a certain functional group, 
namely the imidazole of a histidine residue. The identity of 
the acid-activated receptor was later unmasked by Ludwig 
et al as a family of proton-sensing G protein-coupled recep-
tors (GPCRs). This group identified human ovarian cancer 
GPCR 1 (OGR1) which upon activation will produce inosi-
tol phosphate and calcium efflux through the G
q
 pathway.19 
These pH-sensing GPCR family members, including GPR4, 
GPR65 (TDAG8), and GPR68 (OGR1), will be discussed 
in this review (Figure 1). The proton-sensing GPCRs sense 
extracellular pH by protonation of several histidine residues 
on their extracellular domain. The activation of these proton-







 pathways. Their expression varies in 
different cell types and play critical roles in sensing extra-
cellular acidity and modulating cellular functions in several 
biological systems.
Role for the pH-sensing GPCRs 
in the immune system and 
inflammation
Acidic pH is a main characteristic of the inflammatory 
loci.14,20,21 The acidic microenvironment in inflamed tissue 
is predominately due to the increased metabolic demand 
from infiltrating immune cells, such as the neutrophil. These 
immune cells increase oxygen consumption and glucose 
GPR65 (TDAG8)
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Figure 1 Biological roles and G protein coupling of the pH-sensing GPCRs.
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Acidotic stress and proton-sensing GPCRs
uptake for glycolysis and oxidative phosphorylation. When 
oxygen availability is limited, cells often undergo anaerobic 
glycolysis. This process generates increasing amounts of lactic 
acid, thereby creating a local acidic microenvironment within 
the inflammatory loci.22 This presents a role for the pH-sensing 
GPCR GPR65 (TDAG8) in inflammation and immune cell 
function.23 TDAG8 was originally identified by cloning as an 
orphan GPCR which was observed to be upregulated during 
thymocyte apoptosis.24,25 GPR65 (TDAG8) is predominately 
expressed in lymphoid tissues such as the spleen, lymph 
nodes, thymus, and leukocytes.24–26 It was demonstrated that 
GPR65 inhibited pro-inflammatory cytokine secretion, which 
includes IL-6 and TNF-α, in mouse peritoneal macrophages 
upon activation by extracellular acidification. This cytokine 
inhibition was shown to occur through the G
s
-cAMP-protein 
kinase A (PKA) signaling pathway.23,27 Treatment with dexam-
ethasone, a potent glucocorticoid, increased GPR65 expres-
sion in peritoneal macrophages. Following  dexamethasone 
treatment, there was an inhibition of TNF-α secretion in 
a manner dependent on increased expression of GPR65.28 
Another report provides an anti-inflammatory role for GPR65 
in arthritis.29 Type II collagen-induced arthritis was increased 
in GPR65-null mice in comparison to wild-type mice. These 
studies taken together suggest GPR65 serves as a negative 
regulator in inflammation.30 However, one study provided 
a function for GPR65 as a positive modulator in inflamma-
tion.31 GPR65 was reported to increase eosinophil viability in 
the acidic microenvironment by reducing apoptosis through 
the cAMP pathway. As eosinophils are central in asthmatic 
inflammation and allergic airway disease, GPR65 may play 
a role in increasing asthmatic inflammation.31 On the other 
hand, GPR65 has shown little involvement in immune cell 
development. One report indicates that GPR65 knockout mice 
had normal immune development and function.26 Modulation 
of inflammation by GPR65 is complex and must be examined 
within each specific pathology.23
In addition to GPR65, GPR4 is also involved in the 
inflammatory response. Endothelial cells compose blood 
vessels that often penetrate acidic tissue microenvironments 
such as the inflammatory loci. Among the pH-sensing GPCR 
family, GPR4 has the highest expression in endothelial 
cells. Response to inflammation by vascular endothelial 
cells facilitates the induction of inflammatory cytokines 
that are involved in the recruitment of leukocytes for adher-
ence and transmigration into inflamed tissues. Activation of 
GPR4 by acidosis in human umbilical vein endothelial cells, 
among other endothelial cell types, increased the expression 
of a broad range of pro-inflammatory genes including 
chemokines, cytokines, PTGS2, NF-κB pathway genes, 
and adhesion molecules.32 Moreover, human umbilical vein 
endothelial cells, when treated with acidic pH, increased 
GPR4-mediated endothelial adhesion to leukocytes.32,33 
Altogether, GPR65 and GPR4 provide differential regula-
tion of the inflammatory response through their acid sensing 
capabilities. GPR65 predominately demonstrates function in 
the inhibition of the inflammatory response whereas GPR4 
activation exacerbates inflammation.
Role for the pH-sensing GPCRs in 
the cardiovascular system
The cardiovascular system is essential for the delivery of 
oxygen and nutrients while also removing metabolic waste 
from tissues. Vascular occlusion, however, results in tissue 
ischemia and acidification due to oxygen deprivation, anaero-
bic metabolism, and deficiency to remove acid byproducts. 
Within the cardiac system, acidosis disrupts the regulation of 
action potential duration associated with cardiac excitability.34 
Most notably, this action potential disruption is caused by 
cardiac ischemia and acidosis, which impairs sodium channels 
and can lead to life-threatening events such as arrhythmia, 
myocardial infarction, and cardiac death.35–37
A decrease in interstitial tissue pH may alter angiogenesis.38 
Angiogenesis involves the activation of endothelial cells, 
which line blood vessels, to switch from a quiescent state to 
a vascular-sprouting state, giving rise to a functional blood 
vessel network. This change in active growth can be regulated 
by signaling through hypoxia, acidosis, VEGF, nitric oxide, 
among others.39,40 A decrease in interstitial tissue pH, which 
creates an acidic microenvironment, has been attributed to 
abnormalities in VEGF and VEGF receptor expression and 
signaling. Furthermore, acidosis may inhibit angiogenesis 
depending on the extracellular proton concentration.38
Disturbances in acid-base balance within the cardiovas-
cular system can also influence vascular tone by modulating 
endothelial and smooth muscle interactions and function. 
Intracellular acidosis is associated with vasodilation of large 
arteries; whereas intracellular acidosis initiates vasoconstric-
tion within smaller arteries noted in the pulmonary vascular 
system.41,42 Additionally, a recent study showed that acidic 
pH increased relaxation of human placental arteries.43
The pH-sensing GPCRs have recently been studied as can-
didate acid sensors in the cardiovascular system. The GPR4 
receptor is highly expressed in vascular endothelial cells.33,44 
GPR4 is activated by extracellular acidic pH to initiate signal-
ing cascades which regulate cellular function.19,33,45,46 It has 
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endothelial cells and a regulator of blood vessel stability.47 
Whereas adult GPR4-null mice in the C57BL6/129 mixed 
genetic background were fertile and phenotypically normal, 
there were smaller litter sizes and a higher perinatal mortality 
rate in partial correlation with spontaneous hemorrhaging and 
respiratory distress in a fraction of GPR4-null neonates.47 
Histological analysis revealed GPR4-null neonates with 
hemorrhages exhibiting disorganized and tortuous blood 
vessels associated with reduced mural cell coverage.47 Stud-
ies on another GPR4 knockout mouse strain observed that 
the blood vessels of tumors formed in the GPR4-deficient 
mice were fragmented and fragile, also suggesting that GPR4 
may regulate blood vessel integrity.44 Similar to the previous 
study,47 the phenotype of this GPR4 knockout mouse strain 
was also grossly normal.44 However no perinatal mortality 
was observed in this knockout strain, which might be related 
to differences in mouse strain genetic backgrounds, knockout 
constructs, and breeding conditions. Wyder et al also noted 
that the GPR4-deficient mice showed a reduced angiogenic 
response to VEGF, implicating the involvement of GPR4 in 
VEGF-driving angiogenesis.44 It has been shown that GPR4 
activation by acidosis stimulated the expression of endo-
plasmic reticulum stress response genes such as ATF3 and 
CHOP (DDIT3) in vascular endothelial cells.32,48 Moreover, 
a recent study demonstrated that acidosis/GPR4-induced 
CHOP expression was involved in endothelial cell apoptosis 
in a renal ischemia/reperfusion mouse model.49 These stud-
ies provide evidence that implicate involvement of GPR4 in 
regulating the vascular system.
Another proton-sensing GPCR, GPR68 (OGR1), has also 
shown involvement in the response of the cardiovascular sys-
tem to tissue acidosis. Russell et al identified 3,5-disubstituted 
isoxazoles (lsx), which are cardiomyogenic small molecules 
targeting Notch activated epicardium-derived cells, as agonists 
of the GPR68 receptor.50 GPR68-expressing cardiomyocytes 
formed a proton-sensing cellular buffer zone surrounding the 
infarcted myocardium. Activation of GPR68 by lsx induced 
the expression of cardiomyogenic and pro-survival genes.50 In 
human aortic smooth muscle cells, GPR68 is the major recep-
tor responsible for extracellular acidic pH-induced production 
of inositol phosphate, PGI
2
, and cAMP.51 Additionally, acidic 
pH-induced vascular actions of aortic smooth muscle cells 
can be divided into GPR68-dependent effects such as COX-2 
expression, PGI
2
 production, and MAPK phosphatase-1 
expression and GPR68-independent effects such as PAI-1 
expression and cell proliferation.52
Taken together, both GPR4 and GPR68 play roles in 
regulating the function of the cardiovascular system. GPR4 
regulates blood vessel stability and endothelial cell function 
and GPR68 increases cardiomyogenic and pro-survival gene 
expression while also mediating aortic smooth muscle cell 
gene expression.
Role for the pH-sensing GPCRs in 
the renal system
The human body has several ways to buffer systemic pH to 
maintain normal physiological homeostasis. The physiologi-
cal pH of arterial blood is around pH 7.4. Under pathological 
conditions the body’s blood pH can become acidic (metabolic 
or respiratory acidosis) or basic (metabolic or respiratory 
alkalosis). A physiological response to buffer blood pH can 
occur quickly (minutes) via respiratory activity but may 
also be modified slowly (days) by controlling the level of 
extra-cellular fluid electrolytes through the renal system. 
Respiratory activity can increase via hyperventilation in 





) in the form of a gas (CO
2
). When there are excess 
acids other than CO
2
 in the circulatory system the kidneys 
will excrete them in an effort to restore normal blood pH. 
Chronic kidney disease among other renal impairments can 
result in the damage of functioning glomeruli as well as 
nephrons, which may lead to severe metabolic acidosis. The 
loss of bases through intestinal bicarbonate malabsorption 
in the form of diarrhea may also lead to metabolic acido-
sis, which is one of the most common acid/base problems. 
Metabolic acidosis may lead to poor nutritional status, 
uremic bone disease, and may correlate with patient mortal-
ity.53–55 In addition, acidosis in the kidney has recently been 
found to exacerbate the progression of nephropathy.56,57 As 
some mechanisms of how circulatory pH may be buffered 
in response to metabolic acidosis have been discovered, 
exactly how kidney cells may sense acidosis remains to be 
fully elucidated. Two of the proton-sensing GPCRs, GPR4 
and GPR68, have been studied as pH sensors in the renal 
system.58,59 GPR4 and GPR68 are expressed in the lung and 
kidney, which may both be necessary to successfully buffer 
the circulatory system and maintain pH homeostasis.
GPR4 is expressed in the kidney cortex, isolated kidney 
collecting ducts, inner and outer medulla, and in cultured 
inner and outer medullary collecting duct cells.59 In mice 
deficient for GPR4, renal acid excretion and the ability to 
respond to metabolic acidosis was reduced.59 In response 
to acidosis, inner and outer medullary collecting duct cells 
produced cAMP, a second messenger for the G
s
 G-protein 
pathway, through the GPR4 receptor.59 In renal HEK293 
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Acidotic stress and proton-sensing GPCRs
the activity of PKA.60 In addition, the protein expression 
of H+-K+-ATPase α-subunit (HKα
2
) was increased follow-
ing GPR4 overexpression dependent on increased PKA 
activity.60
GPR68 has also been reported to alter proton export of 
HEK293 cells by stimulating the Na+/H+ exchanger and H+-
ATPase.58 The activation of GPR68 by acidosis was found to 
stimulate this effect through a cluster of extracellular histidine 
residues and the G
q
/PKC signaling pathway.58 In GPR68-
null mice the expression of the pH-sensitive kinase Pyk2 in 
the kidney proximal tubules was upregulated which might 
compensate for GPR68 deficiency.58 Taken together, GPR4 
and GPR68 may both be necessary for successful systemic 
pH buffering by controlling renal acid excretion.
Role for the pH-sensing GPCRs in 
the respiratory system
The primary function of the respiratory system is to provide 
an adequate oxygen supply to tissues while subsequently 
removing carbon dioxide by exhalation. Enhancement of 
gas transport occurs by hemoglobin binding of oxygen and 
bicarbonate transport of carbon dioxide. This mechanism 
maintains an acid/base homeostasis that serves as a required 
pH buffering system. Respiratory acidosis results from an 
alteration in the partial pressures of carbon dioxide, a product 
of cellular metabolism. An increase in carbon dioxide in 
the blood circulation will facilitate proton accumulation by 
means of carbonic acid conversion by carbonic anhydrase. 
Respiratory acidosis has been observed in several respira-
tory diseases, such as chronic obstructive pulmonary disease 
(COPD) and asthma.12,61–63
Asthma is a chronic inflammatory disease, which is 
associated with bronchial hyper-responsiveness, airway 
inflammation, remodeling, and acidic features. Ichimonji 
et al demonstrated in human airway smooth muscle cells 
that GPR68 mediated extracellular acidification-induced 
production of pro-inflammatory cytokine IL-6 and increased 
intracellular Ca2+ concentration.64 The same group also 
found that extracellular acidification of pH 6.3 induced the 
expression of CTGF, which was involved in the formation 
of extracellular matrix proteins and associated with airway 





Furthermore, Saxena et al demonstrated that GPR68 receptor 
mediated airway smooth muscle cell contraction in an acidic 
extracellular environment.66 Inflammatory airway disease is 
also known to have excess mucus excretion, which can be 
exacerbated by exposure to an acidic microenvironment. 
Liu et al showed that airway acidification could induce the 
hyper-secretion of MUC5AC, a protein associated with 
mucus production within the pulmonary tracts, in human 
airway epithelial cells.67
Aoki et al demonstrated that GPR68-deficient mice were 
resistant to asthma along with inhibiting Th2 cytokine and 
immunoglobulin E production.68 This study concludes that 
GPR68 in dendritic cells is crucial for the onset of asthmatic 
responses.68 Moreover, GPR65 has been implicated as hav-
ing a role in respiratory disorders as it is highly expressed 
in eosinophils, hallmark cells for asthmatic inflammation.69 
Kottyan et al showed that GPR65 increased the viability of 
eosinophils within an acidic environment through the cAMP 
pathway in murine asthma models.31 In summary, GPR68 
and GPR65 play important roles in the respiratory system 
and asthma. GPR68 regulates gene expression in airway 
epithelial, smooth muscle and immune cells while GPR65 
enhances the survival of airway eosinophils in response to 
acidosis.
Role for the pH-sensing GPCRs in 
the skeletal system
Recently, pH-sensing GPCRs have been found to be impor-
tant for response to metabolic acidosis in the skeletal system. 
During metabolic acidosis there are several mechanisms to 
restore normal physiological pH as mentioned previously. In 
addition to respiratory CO
2
 excretion and renal acid excre-
tion, the skeletal system also carefully balances systemic 
pH. Acidosis has been reported to directly inhibit osteoblast 
activity, resulting in a reduction in the bone resorbing of 
minerals and Ca2+.3,70,71 Acidosis may also activate osteoclast 
activity to increase Ca2+ release in vitro.71 Ca2+ release and 
mineral dissolution from bone may help systemically buffer 
protons and restore normal physiological pH.72,73 Chronic 
metabolic acidosis can result in a reduction of total volumet-
ric bone density and over time can result in osteoporosis.72 
The reduction in osteoblast activity may also reduce the gene 
expression of several matrix proteins such as COL1A, OPN, 
and MGP, which may contribute to increased osteoarthritis 
development.71,74–76 Two of the pH-sensing G protein-coupled 
receptors, GPR68 and GPR65, have been reported to sense 
acidosis in bone cells.
Among other cell types, there is high expression of GPR68 
in osteoblasts and osteoclasts as well as chondrocytes.19 As 
osteoclast and osteoblast homeostasis may regulate systemic 
pH by controlling the release of minerals from bone, GPR68 
has been speculated as a possible bone acidosis sensor.19,76 
In addition, GPR68 is expressed during osteoclastogenesis 
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has been determined to increase the accumulation of NFATc1 
protein through NF-kappa B ligand (RANKL) in the nuclei 
of rat and rabbit osteoclasts.78 This was proposed to occur 
through prolonged Ca2+ release and the sequential activation 
of the calcineurin/NFAT pathway in response to GPR68 acti-
vation by acidosis.78 In normal human osteoblast (NHOst) 
cells acidosis has been found to stimulate the expression 
of COX2 and PGE
2
 through the GPR68-mediated G
q
/
PLC/Ca2+ signaling pathway.79 GPR68 is also expressed in 
cultured neonatal calvariae osteoblasts and in response to 
acidosis may increase intracellular Ca2+ release.76 Further-
more, following the transfection of a heterologous GPR68 
construct into Chinese hamster ovary cells, the response to 
acidosis stimulated the intracellular release of Ca2+ as well.76 
GPR68 expression in rat endplate chondrocytes was found 
to induce apoptosis in response to acidosis,80 which could 
reduce collagen production and lead to intervertebral disk 
degeneration.
GPR65 has also been reported as a pH sensor in bone. 
GPR65 is expressed in osteoclasts and its activity may inhibit 
Ca2+ resorption.81 Disruption of GPR65 gene exacerbated 
osteoclastic bone resorption in ovariectomized mice.81 The 
relative bone density of GPR65-null mice was less than con-
trol mice.81 In cultured osteoclast cells from mice deficient 
for GPR65, the normal inhibition of osteoclast formation 
in response to acidosis was abrogated.81 Taken together, 
this data suggest that the activation of GPR65 may enhance 
bone density, thus the GPR65 signaling may be important 
for disease processes such as osteoporosis and other bone 
density disorders.
Role for the pH-sensing GPCRs in 
the endocrine system
The effects of metabolic acidosis have been studied in the 
endocrine system. Metabolic acidosis can alter insulin 
secretion as well as pancreatic function,82 which is relevant 
in disease states such as diabetes. Recently, the pH-sensing 
GPCRs, GPR4 and GPR68, have been found to be involved 
in insulin secretion and tissue sensitivity to insulin.83,84 In 
GPR4 knockout mice glucose tolerance was augmented by 
increasing the sensitivity to insulin.83 The balance of pro-
inflammatory and anti-inflammatory molecules are crucial 
for the maintenance of insulin sensitivity as pro-inflammatory 
cytokines can further promote insulin resistance and type 
II diabetes.85 The absence of GPR4 may reduce the expres-
sion of several inflammatory modulators in white adipose 
tissue such as IL-6 and PPARα and an increase in TNF-α 
and TGF1-β.83 GPR4 is also highly expressed in endothelial 
cells, which when activated has been reported to stimulate 
the expression of inflammatory genes.32,33
GPR68 has also been found to modify insulin production 
and secretion. In GPR68 knockout mice insulin secretion 
in response to glucose administration was reduced when 
compared to wild-type mice although blood glucose was 
not significantly altered.84 GPR68 deficiency in this respect 
may reduce insulin secretion but at the same time increase 
insulin sensitivity. In addition, stimulation of GPR68 in islet 




Role for the pH-sensing GPCRs in 
the nervous system and nociception
Acidosis causes pain by exciting nociceptors located in sen-
sory neurons. Several types of ion channels and receptors, 
such as ASICs, TRPV1, and proton-sensing GPCRs, have 
been identified as nociceptors in response to acidosis. ASICs 
and TRPV act as proton-gated membrane-bound channels, 
which are activated by acidic pH and mediate multimodal 
sensory perception including nociception.86–88 It has also 
been reported that acidosis causes excitation or modula-
tion of nociceptive sensory neurons through proton-sensing 
GPCRs.89 All proton-sensing GPCRs are localized in the 
dorsal root ganglia that are the pain-relevant loci.89 Chen 
et al demonstrated the involvement of GPR65 in inflamma-
tory pain by using mouse models with injection of capsaicin, 
carrageenan, and complete Freund’s adjuvant.89 Notably, 
GPR65 activation sensitized the response of TRPV1 to 
capsaicin. The results suggest high accumulation of protons 
post inflammation may not only stimulate nociceptive ion 
channels such as TRPV1 to trigger pain, but also activate 
proton-sensing GPCRs to regulate heightened sensitivity to 
pain.89 Furthermore, Hang et al demonstrated GPR65 activa-
tion elicited cancer-related bone pain through the PKA and 
phosphorylated CREB (pCREB) signaling pathway in the 
rat model.90 Collectively, GPR4, GPR65, and GPR68 are all 
expressed in the dorsal root ganglia; GPR65 is a functional 
receptor involved in nociception and the nervous system by 
sensitizing inflammatory pain and the evocation of cancer-
related bone pain.
Role for the pH-sensing GPCRs in 
tumor biology
The tumor microenvironment is highly heterogeneous. 
Hypoxia, acidosis, inflammation, defective vasculature, poor 
blood perfusion, and deregulated cancer cell metabolism are 
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Acidotic stress and proton-sensing GPCRs
in the tumor microenvironment is owing to the altered 
cancer cell metabolism termed the “Warburg Effect”. This 
metabolic phenotype allows the cancer cells to preferentially 
utilize glycolysis over oxidative phosphorylation as a primary 
means of energy production.94 This process occurs even in 
normoxic tissue environments where sufficient oxygen is 
available. Due to this phenomenon, the Warburg Effect is 
often termed “aerobic glycolysis”. This unique metabolic 
phenotype produces vast quantities of lactic acid, which serve 
as a proton source for acidification. Upon disassociation of 
lactic acid to one lactate molecule and one proton, the mono-
carboxylate transporter and proton transporters export lactate 
and protons into the extracellular tumor microenvironment.95 
The proton-sensing GPCRs are activated by acidic pH and 
facilitate tumor cell modulation in response to extracellular 
acidification. GPR4, GPR65, and GPR68 play roles in tumor 
cell apoptosis, proliferation, metastasis, angiogenesis, and 
immune cell function.19,27,32,33,44,45,96,97
GPR4 has had conflicting reports in terms of tumor sup-
pressing or promoting activities. One study demonstrated 
that GPR4 could act as a tumor metastasis suppressor, 
when overexpressed and activated by acidic pH in B16F10 
melanoma cells, by impeding migration and invasion of 
tumor cells.45 GPR4 overexpression also significantly 
inhibited the lung metastasis of B16F10 melanoma cells 
in mice.45 Another study utilizing the B16F10 melanoma 
cell line which overexpressed GPR4 showed an increase in 
mitochondrial surface area and a significant reduction in 
membrane protrusions by quantification of 3D morphology.98 
These data point to a decrease in cancer cell migration when 
GPR4 is  overexpressed and provides another example of 
GPR4 as exhibiting tumor metastasis suppressor function.98 
However, in another report GPR4 malignantly transformed 
immortalized NIH3T3 fibroblasts.99 This presents GPR4 with 
tumor-promoting capabilities. The conflicting reports seem 
to indicate the functional ability of GPR4 to act as a tumor 
promoter and a tumor suppressor depending on the context 
of certain cell types and biological systems.
Reports with GPR65 involvement in cancer cells 
provide evidence in favor for cancer cell survival; how-
ever, opposing evidences suggest GPR65 functions as a 
tumor suppressor. In the same report suggesting GPR4 
is oncogenic due to GPR4 transforming immortalized 
NIH3T3 fibroblasts, GPR65 overexpression was able to 
transform the mouse NMuMG mammary epithelial cell 
line.99 Another group demonstrated in NCI-H460 human 
non-small cell lung cancer cells that GPR65 promotes 
cancer cell survival in an acidic microenvironment.100 
Conversely, a recent study showed that GPR65 inhibited 
c-Myc oncogene expression in human lymphoma cells.101 
Furthermore, GPR65 messenger ribonucleic acid expres-
sion was reduced by more than 50% in a variety of human 
lymphoma samples when compared to normal lymphoid 
tissues, therefore implying GPR65 has a tumor suppres-
sor function in lymphoma.101 GPR65 has also been shown 
to increase glucocorticoid-induced apoptosis in murine 
lymphoma cells.102 These reports highlight cell type depen-
dency and biological context for GPR65 activity as a tumor 
suppressor or promoter.
GPR68 also has roles in tumor biology as a potential 
tumor suppressor or a tumor promoter. Reports have shown 
that GPR68 can inhibit cancer metastasis, reduce cancer 
cell proliferation, and inhibit migration. One study showed 
that when GPR68 was overexpressed in prostate cancer 
cells, metastasis to the lungs, diaphragm, and spleen was 
inhibited.97 When GPR68 was overexpressed in ovarian 
cancer (HEY) cells, cellular proliferation and migration 
were significantly reduced, and cell adhesion to the extra-
cellular matrix was increased.96 Another study reported 
GPR68 expression was critical for the tumor cell induced 
immunosuppression in myeloid-derived cells. This study 
proposed that GPR68 promotes M2 macrophage develop-
ment and inhibits T-cell infiltration, and thereby facilitates 
tumor development.103 In summary, the biological roles of 
GPR4, GPR65, and GPR68 in tumor biology are complex 
and both tumor-suppressing and tumor-promoting functions 
have been reported, primarily dependent on cell type and 
biological milieu.
Development of small molecule 
modulators of the pH-sensing 
GPCRs
GPCRs are critical receptors for the regulation of many 
physiological operations. It is of little surprise that GPCRs 
have become a central focus of pharmaceutical development. 
In fact, 30%–50% of therapeutics focuses on modulating 
GPCR activity.104,105 In view of the diverse roles of the 
pH-sensing GPCRs in the context of multiple biological 
systems, targeting these receptors with small molecules 
and other modulators could serve as potential therapeutics 
for diseases associated with deregulated pH homeostasis. 
There have been recent developments in the characteriza-
tion of GPR4 antagonists along with agonists for GPR65 
and GPR68.29,32,50,106 The GPR4 antagonist demonstrated 
effectiveness in vitro to reduce the GPR4-mediated inflam-
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agonist, BTB09089, showed in vitro effects in GPR65 acti-
vation of immune cells to inhibit inflammatory response; 
however, the activity of BTB09089 was not strong enough for 
the use in animal models in vivo.29 The GPR68 agonist, lsx, 
exhibited pro-neurogenic activity and induced hippocampal 
neurogenesis in young mice.107 It was also demonstrated that 
lsx suppressed the proliferation of malignant astrocytes.108 
To date, however, much advancement needs to be done in 
development of efficacious agonists and antagonists of the 
pH-sensing GPCRs coupled with a capacity to target specific 
tissue dysfunction in the midst of systemic drug administra-
tion to optimize therapeutic effects and minimize potential 
adverse effects.
Concluding remarks
Cells encounter acidotic stress in many pathophysiologic 
conditions such as inflammation, cancer, and ischemia. 
Intricate molecular mechanisms, including a large array of 
acid/base transporters and acid sensors, have evolved for cells 
to sense and respond to acidotic stress. Emerging evidence 
has demonstrated that a family of the pH-sensing GPCRs 
can be activated by extracellular acidotic stress and regulate 
the function of multiple physiological systems (Table 1). 
The pH-sensing GPCRs also play important roles in vari-
ous pathological disorders. Agonists, antagonists and other 
modulators of the pH-sensing GPCRs are being actively 
developed and evaluated as potential novel treatment for 
acidosis-related diseases.
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Table 1 The main biological functions of the pH-sensing GPCRs
System GPR65 (TDAG8) GPR4 GPR68 (OGR1)
immune and  
inflammation 
Inhibits pro-inflammatory cytokine  
secretion in macrophages and  
suppresses inflammatory response  
in mice.23,27–29 
enhances eosinophil survival under 
acidosis.31
Induces inflammatory gene  
expression in response to acidosis  
in endothelial cells.32 
increases leukocyte-endothelial  
cell adhesion.32,33
N/A
Cardiovascular N/A Regulates blood vessel stability and  
integrity.44,47
increases expression of cardiomyogenic 
and pro-survival genes in the heart; as 
well as mediates gene expression in aortic 
smooth muscle cells.50–52
Renal N/A Regulates renal acid excretion  
in mice and H+-K+-ATPase 
expression.59,60
Regulates proton transporter activity and 
proton extrusion in the kidney.58
Respiratory Implicated in asthmatic inflammation.31 N/A Regulates gene expression and airway 
smooth muscle cell contraction.64–67  
GPR68-null mice are resistant to asthma.68
Skeletal inhibits osteoclastic bone resorption;  
relative bone density is reduced in  
GPR65-null mice.81
N/A Regulates gene expression in response to 
acidosis in bone cells.19,76,78,79 
GPR68 activation by acidosis stimulates 
apoptosis in chondrocytes.80
endocrine N/A Regulates inflammatory gene  
expression in insulin target tissues;  
insulin sensitivity is increased in  
GPR4-null mice.83




Sensitizes inflammatory pain and  
cancer-related bone pain.89,90
expressed in dorsal root ganglia.89 expressed in dorsal root ganglia.89
Tumor biology Transforms NMuMG mammary  
epithelial cell line.99 
inhibits c-Myc oncogene expression  
in human lymphoma cells.101 
enhances glucocorticoid-induced  
apoptosis in murine lymphoma cells.102
Overexpression inhibits B16F10  
melanoma cell migration, invasion,  
and metastasis.45,98 
Overexpression transforms  
immortalized NIH3T3 fibroblasts.99
Overexpression in prostate cancer cells 
suppresses metastasis to lungs, diaphragm, 
and spleen in mice.97 
Overexpression inhibits ovarian cancer cell 
proliferation and migration.96 
induces immunosuppression and promotes 
tumor development in mice.103
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